NewEdge Advisors’s Matinas BioPharma MTNB Stock Holding History

NewEdge Advisors’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1	Closed	-$1	–	4098
2025 Q1	$1	Hold	1	–	–	﹤0.01%	3947
2024 Q4	$1	Buy	+1	New	+$2	﹤0.01%	3896

Other funds holding MTNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIW

Holos Integrated Wealth Kennett Square, Pennsylvania $214M AUM 14.99% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

NewEdge Advisors's MTNB Position: Q2 2025 in Review

NewEdge Advisors sold out of Matinas BioPharma (MTNB) in Q2 2025, closing a stake of 1 share — an estimated $1 sold.

NewEdge Advisors first reported a position in MTNB in Q4 2024 and held it in 2 quarters. The position peaked at $1 in Q1 2025. 24 funds tracked by Wall St. Rank hold MTNB as of Q2 2025.

NewEdge Advisors reported no remaining Matinas BioPharma position as of Q2 2025 after selling out during the quarter.
NewEdge Advisors sold 1 Matinas BioPharma share in Q2 2025, an estimated $1.
NewEdge Advisors first reported a position in Matinas BioPharma in Q4 2024 and held it in 2 quarters.
NewEdge Advisors's Matinas BioPharma position peaked at $1 in Q1 2025.
24 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2025.

Based on NewEdge Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.